These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30323205)

  • 1. Prefrontal expectancy and reinforcement-driven antidepressant placebo effects.
    Peciña M; Heffernan J; Wilson J; Zubieta JK; Dombrovski AY
    Transl Psychiatry; 2018 Oct; 8(1):222. PubMed ID: 30323205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic Feedback Between Antidepressant Placebo Expectancies and Mood.
    Peciña M; Chen J; Karp JF; Dombrovski AY
    JAMA Psychiatry; 2023 Apr; 80(4):389-398. PubMed ID: 36857039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. μ Opioid Antagonist Naltrexone Partially Abolishes the Antidepressant Placebo Effect and Reduces Orbitofrontal Cortex Encoding of Reinforcement.
    Peciña M; Chen J; Lyew T; Karp JF; Dombrovski AY
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Oct; 6(10):1002-1012. PubMed ID: 33684624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural mechanisms of expectancy-based placebo effects in antidepressant clinical trials.
    Zilcha-Mano S; Wang Z; Peterson BS; Wall MM; Chen Y; Wager TD; Brown PJ; Roose SP; Rutherford BR
    J Psychiatr Res; 2019 Sep; 116():19-25. PubMed ID: 31176108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant study design affects patient expectancy: a pilot study.
    Rutherford B; Sneed J; Devanand D; Eisenstadt R; Roose S
    Psychol Med; 2010 May; 40(5):781-8. PubMed ID: 19732481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressive effect of left dorsolateral prefrontal cortex neurofeedback in patients with major depressive disorder: A preliminary report.
    Takamura M; Okamoto Y; Shibasaki C; Yoshino A; Okada G; Ichikawa N; Yamawaki S
    J Affect Disord; 2020 Jun; 271():224-227. PubMed ID: 32479320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.
    Peciña M; Bohnert AS; Sikora M; Avery ET; Langenecker SA; Mickey BJ; Zubieta JK
    JAMA Psychiatry; 2015 Nov; 72(11):1087-94. PubMed ID: 26421634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.
    Cardoso EF; Fregni F; Martins Maia F; Boggio PS; Luis Myczkowski M; Coracini K; Lopes Vieira A; Melo LM; Sato JR; Antonio Marcolin M; Rigonatti SP; Cruz AC; Reis Barbosa E; Amaro E
    Int J Neuropsychopharmacol; 2008 Mar; 11(2):173-83. PubMed ID: 17708780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials.
    Rutherford BR; Wall MM; Brown PJ; Choo TH; Wager TD; Peterson BS; Chung S; Kirsch I; Roose SP
    Am J Psychiatry; 2017 Feb; 174(2):135-142. PubMed ID: 27609242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline functional connectivity may predict placebo responses to accelerated rTMS treatment in major depression.
    Wu GR; Wang X; Baeken C
    Hum Brain Mapp; 2020 Feb; 41(3):632-639. PubMed ID: 31633261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Neurocomputational Mechanisms of Antidepressant Placebo Effects.
    Peciña M; Dombrovski AY; Price R; Karim HT
    J Psychiatr Brain Sci; 2021; 6():. PubMed ID: 33732892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design.
    Falkenberg I; Bitsch F; Liu W; Matsingos A; Noor L; Vogelbacher C; Yildiz C; Kircher T
    Trials; 2023 Aug; 24(1):514. PubMed ID: 37568215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does prior antidepressant treatment of major depression impact brain function during current treatment?
    Hunter AM; Cook IA; Leuchter AF
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder.
    Dunlop BW; Rajendra JK; Craighead WE; Kelley ME; McGrath CL; Choi KS; Kinkead B; Nemeroff CB; Mayberg HS
    Am J Psychiatry; 2017 Jun; 174(6):533-545. PubMed ID: 28335622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant short-term and long-term brain effects during self-referential processing in major depression.
    Delaveau P; Jabourian M; Lemogne C; Allaïli N; Choucha W; Girault N; Lehericy S; Laredo J; Fossati P
    Psychiatry Res Neuroimaging; 2016 Jan; 247():17-24. PubMed ID: 26655583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
    Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder.
    Park L; Furey M; Nugent AC; Farmer C; Ellis J; Szczepanik J; Lener MS; Zarate CA
    Int J Neuropsychopharmacol; 2019 Jan; 22(1):10-18. PubMed ID: 30184133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, prospective pilot study of patient expectancy and antidepressant outcome.
    Rutherford BR; Marcus SM; Wang P; Sneed JR; Pelton G; Devanand D; Duan N; Roose SP
    Psychol Med; 2013 May; 43(5):975-82. PubMed ID: 22971472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural mechanisms of cognitive reappraisal in remitted major depressive disorder.
    Smoski MJ; Keng SL; Schiller CE; Minkel J; Dichter GS
    J Affect Disord; 2013 Oct; 151(1):171-7. PubMed ID: 23796796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.